Category: Disclosures

[Disclosure] Hanwha Aerospace (012450) – Investor Relations (IR) Holding / 2025-11-14

November 14, 2025August 9, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hanwha Aerospace disclosed that it will hold an Investor Relations (IR) conference in Singapore for major foreign institutional investors to present its current business status and strategies. 📊 [Key Disclosure Contents & Summary of Figures] [IR Event Details] [IR Materials & Other Considerations] 📝 Editor’s Comment…

Disclosures, Defense

[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2025-11-14

November 14, 2025July 31, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanmi Semiconductor is hosting an IR event in Hong Kong for major overseas institutional investors to present its 2026 global growth strategy and memory semiconductor TC Bonder roadmap. 📊 [Key Disclosure Contents & Summary of Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Official…

Semiconductors, Disclosures

[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2025-11-14

November 14, 2025July 31, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanmi Semiconductor is hosting an IR event in Singapore for overseas institutional investors to present its 2026 global growth strategy and product roadmap for AI semiconductor equipment. 📊 [Key Disclosure Contents & Summary of Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Official IR…

Semiconductors, Disclosures

[Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2025-11-13

November 13, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has issued a correction disclosure extending the disclosure postponement period, specifying the contract end date, and updating the counterparty disclosure schedule to August 1, 2031, at the customer’s request regarding the contract manufacturing agreement originally disclosed on November 28, 2019. 📊 [Key Disclosure Details…

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2025-11-13

November 13, 2025August 7, 2026 K-STOCK Editor

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2025-11-13

November 13, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has issued a correction disclosure extending the disclosure postponement period, specifying the contract end date, and updating the counterparty disclosure schedule to March 8, 2033, at the customer’s request regarding the contract manufacturing agreement originally disclosed on April 26, 2019. 📊 [Key Disclosure Details…

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2025-11-13

November 13, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has issued a correction disclosure extending the disclosure postponement period, specifying the contract end date, and updating the counterparty disclosure schedule to March 8, 2033, at the customer’s request regarding the contract manufacturing agreement originally disclosed on May 14, 2019. 📊 [Key Disclosure Details…

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2025-11-13

November 13, 2025August 7, 2026 K-STOCK Editor

Disclosures, Bio & Healthcare

[Disclosure] KEPCO (015760 / KEP) – Provisional Consolidated Earnings Notice / 2025-11-13

November 13, 2025August 12, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART Market: KOSPI (015760) 💡 3-Second Summary KEPCO reported a Q3 2025 consolidated operating profit of KRW 5.65 trillion and a 9-month cumulative consolidated operating profit of KRW 11.54 trillion, up 94.1% YoY. 📊 Key Disclosure Content & Financial Highlights • Disclosure Title: Provisional Consolidated Operating Results (Fair Disclosure) •…

Disclosures, Energy

[Disclosure] SK square (402340) – (Correction) Decision on Acquisition of Treasury Shares / 2025-11-13

November 13, 2025July 31, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK square has decided to acquire KRW 100B worth of its own common shares directly through the open market for shareholder value enhancement and employee stock compensation, while issuing a correction on its daily buy order limit. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s…

Semiconductors, Disclosures